Atovaquone Suspension
Product Images NDC 68462-421

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 68462-421). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure diagram of atovaquone, showing the arrangement of its aromatic rings, hydroxyl group, carbonyl groups, and a chlorine-substituted phenyl ring.*

FDA Label Image

Logo (Logo)

FDA Label Image

Label (Label)

Label for Atovaquone Oral Suspension USP 750 mg/5 mL by Glenmark Pharmaceuticals Inc., USA. The label indicates a 210 mL bottle, with storage instructions between 20°C to 25°C (68°F to 77°F) and caution to shake gently before use. It displays the product NDC 68462-421-21 and includes a barcode and distributor contact information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.